New Biotech Co. Plans To Find Treatment for Alzheimer, Parkinson and ALS Proteins
Diseases affecting the brain and central nervous system represent one of the largest healthcare challenges and greatest unmet medical needs in the world today. This week, a renowned biotech leader Tony Coles, M.D. launched Yumanity Therapeutics, a startup that will use discoveries about yeast to develop new treatments for Parkinson's, Alzheimer's, and ALS, also known as Lou Gehrig's disease.
Be the first to comment